FDA records linked by MedtechLedger identify Ezisurg Medical Co., Ltd. as the applicant on a traditional 510(k) for powered endoscopic staplers and cartridges, with a decision description of Substantially Equivalent. The manufacturer’s published documentation describes the same easyEndo™ E-Lite line and places it within a broader surgical stapling series. The filing address in Shanghai is a regulatory correspondence detail, not a verified headquarters. [1][3][7]
The documented FDA filing
K254291 covers the easyEndo™ E-Lite Single Use Powered Endoscopic Staplers, the same device with a curved tip, and easyEndo™ E-Lite Single Use Cartridges. The record lists product code GDW, regulation number 878.4750, device class 2, advisory committee SU, and a summary statement. The application was received on December 31, 2025, and the decision is dated September 25, 2026. [1]
The applicant field reads Ezisurg Medical Co., Ltd., with a Shanghai address and country code CN. The clearance type is Traditional and the third-party flag is N. The decision code is SESE, described as Substantially Equivalent. [1]
Product line as published by the manufacturer
Ezisurg Medical’s product pages list easyEndo™ E-Lite under a surgical stapling series, with the tagline “3E solution for Ideal Control.” The same page states that the device meets enhanced safety with a one-touch firing mechanism and benefits from improved maneuverability. These are manufacturer descriptions, not independently verified performance results. [3][7]
The product listing also names easyEndo™ UniPlus, described as “Lighter in Hand, Greater in Performance,” and easyEndo™ Universal, described as linear cutting staplers and loading units for single use. The catalog organizes these under surgical stapling, alongside energy sealing and dissecting and endoscopy platforms. [7][8]
Company identity and scope
The company profile states that EziSurg Medical Co., Ltd. was established in November 2011 in Shanghai and specializes in research, development and industrialization. That statement comes from the manufacturer’s own profile page. No parent company, brand owner or corporate affiliate is verified in the available records. [6]
A manufacturer news item dated September 24, 2026 announces that the easyEndo™ E-Lite powered endoscopic stapler received FDA clearance. The FDA record’s decision date is September 25, 2026, one day later. The announcement is the manufacturer’s account; the FDA record is the regulatory source for the clearance. [1][4]
What the collection shows
The linked collection contains one 510(k) record, K254291, and its decision count is one SESE. The record sample is the same single filing, so the sample decision count is also one SESE. These figures describe the linked filings as of the snapshot date and are not measures of total company sales, total portfolio or safety performance. [1]
No recall records are included in the linked collection. Absence of recall entries in this collection does not establish the absence of recalls, and no postmarket conclusion should be drawn from it. [1]

